The possibility of deoxofluorination of -keto esters using SF 4 was investigated. The scope and limitation of the reaction were determined. The efficient method for the synthesis of ,-difluorocarboxylic acids was elaborated based on the reaction. The set of mentioned acids, being the perspective building blocks for medicinal chemistry, were synthesized on multigram scale. The safety of SF 4 use was discussed. The described method does not improve upon the safety of using SF 4 , but practical recommendations for working with the reagent are proposed. Despite the hazards of using toxic SF 4 , a significant increase of efficacy in the synthesis of medicinal-chemistry-relevant building blocks, based on the reaction, in comparison with earlier described approaches is shown.
There are many efficient reagents for organic synthesis known from the classical textbooks, but by no means are all of them popular among chemists for real application in laboratory practice. Gaseous or volatile compounds which possess extremely high toxicity, like CH 2 N 2 , HCN, COCl 2 , and MeNCO, are among the most characteristic examples. The Bhopal disaster, where approximately 200,000 people were exposed to MeNCO and around 20,000 died as a result, has clearly demonstrated such reagents as actually dangerous. 1 Lately some of the above-mentioned reagents are experi-encing a renaissance due to achievements in flow technology. For example, during the last 10 years the safe flow method using CH 2 N 2 2 and HCN 3 has been developed. Another, more common way of obtaining the same results, as in the case of using the dangerous reagents, is development of their less toxic, more convenient, and safe synthetic equivalents. Thus Me 3 SiCHN 2 , 4 Me 3 SiCN, 5 triphosgene, 6 and MeN-HCO 2 CH 2 CF 3 7 were successfully introduced into organic synthesis. But despite the great achievements in modern reagent and technique developments, some synthetic transformations, which require extremely toxic and hazardous gaseous reagents are still remaining. SF 4 is not so common reagent in comparison with the discussed above, but it is a key compound in organofluorine chemistry. 8 The compound is a colorless, highly reactive, and corrosive gas (bp -38 °C), possessing extreme toxicity (LD 50 = 19 ppm (86 mg/m 3 , 4 h, rats 9 )). Also, SF 4 causes burns on unprotected skin due to formation of HF and SOF 2 as a result of hydrolysis. Of course, such properties of SF 4 significantly limited its application in synthesis, especially in regular laboratories. Nevertheless, unique properties of SF 4 in substitution of carbonyl oxygen with two fluorine atoms are very attractive. This is making development of more safe and convenient SF 4 -based analogues like DAST (Et 2 NSF 3 ) and XtalFluor-E ([Et 2 N + =SF 2 ]BF 4 -) or other similar reactants like fluoroamine reagents (FAR) very important. 10 Such replacement of reagents is successful, but it does not always happen. Fluorination of carboxylic acids to CF 3 derivatives is one of the most known examples to the contrary. This process proceeds smoothly under SF 4 treatment, but in the case of DAST or XtalFluor-E the reaction stops at the fluoroanhydride formation step. There is only one successful example described -Fluolead (4-tert-Butyl-2,6-dimethylphenylsulfur trifluoride), which is used for fluorination of carboxylic acids to CF 3 derivatives instead of SF 4 . 11 However, Fluolead is a rather expensive reagent, therefore this approach does not find further application. In this work we describe another example of utilizing SF 4 as unique deoxofluorinative reagent, like cited above. As a part of our ongoing efforts on design and synthesis of advanced reagents for medicinal chemistry 12 and especially functionalized gem-difluoro derivatives 13 , we chose -keto esters, the precursors for ,difluorocarboxylic acids, promising building blocks for medicinal chemistry, as substrates for the fluorination.
The products of deoxofluorination of -keto esters are corresponding ,-difluorocarboxylic acids, building blocks of high value to medicinal chemistry. Some recent representative examples A-F of such building blocks from medicinal chemistry programs related to different therapeutics areas are shown in Figure 1 . 14 In spite of wide use of ,-difluorocarboxylic acids as building blocks by big pharma and biotech companies, direct and efficient approaches to their synthesis are still unknown. The analysis of compounds presented in the literature reveals, that many of them are known, but available only from commercial sources without any information about synthetic routes and procedures.
The first attempts of deoxofluorination of -keto esters were made in the early 1980s by L. M. Yagupol'skii and coworkers. 15 As were shown in these seminal researches, the reaction was accompanied by side dehydrofluorination processes, the impact of which could be decreased by reducing the temperature (Scheme 1). Therefore, the reaction in HF media at room temperature could be considered as preparative. 16 Nevertheless, all attempts to replace SF 4 by DAST failed. Unexpectedly, in this reaction DAST, introducing an additional fluorine into the molecule, formally oxidizes the substrate. 17 In our previous investigations we also tried to optimize the reaction and replaced SF 4 with DAST-type reagents, but all our attempts failed as well. In consequence an alternative synthetic route was proposed. 18 The strategy was based on three-step transformation of the ester function into a nonacceptor CH 2 OAc group, which allowed DAST-based deoxofluorination. The further deacylation/oxidation led to desired ,-difluorocarboxylic acids. In spite of successful realization of the strategy additional six-step sequence was needed, so the total yields were in 14-16% range. Such avoiding of SF 4 is justified for the small-scale synthesis but inefficient for the further scale-up. Therefore, we decided to test diverse deoxofluorination reactions of keto esters with hazardous SF 4 in autoclave conditions and scale them up to hundred grams.
Firstly, we tested the reaction of deoxofluorination by SF 4 with and without addition of HF at different temperatures and different ethylacetoacetate/SF 4 ratios using the simplest ethylacetoacetate (1a) as a model compound. It was found that in the absence of HF, the reaction proceeded nonselectively with predominant dehydrofluorination to the product 3 at 100 °C, as well as at 25 °C. The fraction of dehydrofluorination was dramatically decreased by addition of HF to the system, and at 25 °C a significant selectivity of formation of ,-difluorocarboxylic ester 2a was achieved (Scheme 1). Further optimization showed that the most favorable was the amount of HF of 0.8 mL per 1 g of ethylacetoacetate, the ratio of SF 4 /keto ester = 1.7:1, and the reaction time of 10 h. Using these conditions, we performed 
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the reaction on 100 g scale of ethylacetoacetate in 1.2 L Hastelloy autoclave. The level of dehydrofluorination was less than 5% and as a result the desired ,-difluorocarboxylic ester 2a was isolated in preparative 70% yield.
For the investigation of scope and limitation of the developed protocol, a diverse set of substrates were chosen. Acetoacetic ester derivatives 1a-g, their mono-and dialkylsubstituted analogues 1h-k and 1l-o, respectively, functionalized acetoacetic ester derivatives 1p-s and cyclic keto esters 1t-y were presented among them. The nonenolizable dialkylated derivatives 1h-k were added to the set for checking the influence of possible enol formation as the reaction occurs. Also, the set of functionalized acetoacetic esters 1p-s were tested for the group-tolerance determination, and derivatives 1t-y to examine the impact of conformational restriction ( Figure 2 ).
These substrates were tested in deoxofluorination reaction with SF 4 /HF system according to the aforementioned optimized protocol for ethylacetoacetate (1a). 19 The procedure appeared to be suitable for most -keto esters except for the substrates highlighted in boxes in Figure 2 . Treatment of compounds 1d, 1r, and 1s with SF 4 /HF led to complex undefined mixture of products, the desired dehydrofluorinated compounds were not observed. The cyclopropane derivative 1d probably decomposed via cyclopropylmethyl/cyclobutyl cation rearrangement, which we had observed during fluorinations earlier. 20 Decomposition of 1r in the reaction conditions was unexpected due to our previous successful experience with DAST fluorination of TFA-protected amino ketones, 18 while decomposition of the substrate 1s was anticipated. According to our previous expertise fluorination of compounds containing PhCH 2 O fragment by SF 4 led to debenzylation with subsequent unselective decomposition. It should be noted that compound 1w, bearing an ether fragment, also did not give the desired product in the SF 4 /HF system. In this case the compound having m/z [M + ] = 286 in GC-MS and m/z [M + 1] = 287 in positive mode in APCI HPLC MS was observed as a major product, but we were not able to determine its structure based on these results as well as on NMR data. Nevertheless, the product 1w was successfully deoxofluorinated by SF 4 in the absence of HF at 60 °C in 61% preparative yield, 21 which was a rare exception to our procedure. The rate of dehydrofluorination in this case was less than 10%. Substrates 1e, 1j, and 1v also reacted unselectively under the optimized conditions, but the corresponding deoxofluorinated products were registered at about 10%, making the proce- This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.
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dure nonpreparative. The results of deoxofluorination of keto esters 1 are summarized in Table 1 . The preparative yields obtained using the above-mentioned substrate set are high (from 55-90%) and comparable for both enolizable and nonenolizable keto esters. Considerable rate of dehydrofluorination was observed in the case of using substrates 1u (up to 20%), 1c, 1h (up to 10%), and 1b, 1i (up to 5%). 
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The reaction was scaled up to 50-150 g (0.3-0.9 mol) of starting material from one synthetic run without changing the protocol. Such amounts required operating with significant quantity, up to 175 g, of SF 4 for one run. These operations were performed in the special well-ventilated laboratory with strictly limited staff access due to safety reasons. The staff always wear the personal-protection equipment including single-filter, full-face masks during operation in accordance with international safety regulations. 22 The damper technique applied for loading of SF 4 into the autoclave was shown in Figure 3 . The standardized damper chambers were used, which contained 25±1 g of SF 4 at atmospheric pressure. The excess of SF 4 , along with the other gaseous byproducts, is vented from the autoclave through a KOH solution after the reaction is complete.
All obtained ,-difluoroesters 2 were subjected to subsequent hydrolysis into the corresponding acids. Taking into account unsustainability of enolizable ,-difluoroesters to fluorine anion elimination, 23 the acidic condi-tions 24 were chosen for hydrolysis. In the case of nonenolizable ,-difluoroesters 2e,f and 2l-o more convenient alkali hydrolysis was applied. 25 The corresponding acids were obtained in good preparative yields under both conditions ( Table 1) .
The next milestone of the investigation was the elaboration of an efficient method for the synthesis of Medicinal chemistry relevant difluorinated cyclic amino acid derivatives type 11 starting from readily available compounds type 12 (Scheme 2). Earlier, this methodology was applied only for the 3,3-difluoroproline derivative 11c. Recently, the preparative deoxofluorination of the corresponding precursor, where PG = Cbz and R = t-Bu, was described using DAST as a reagent. 26 The approaches to derivatives of amino acids 11b and 11c were also described based on another methodology. The 3,3-difluoroisonipecotic acid derivatives were obtained via multistep synthesis starting from ethyl bromodifluoroacetate as CF 2 moiety source. 27 In the case of 4,4-difluoro--proline the core was assembled 
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by [3+2] cycloaddition of azomethine ylide with benzyl 3,3difluoroacrylate. 28 At first, we chose the NBn-protected compounds 12a-d as potential substrates for deoxofluorination. These compounds were examined in a standard protocol with SF 4 in HF. Among them substrates 12a-c gave the corresponding difluoro derivatives 11a-c in good preparative yields (from 68-83% on 0.6 mol scale of starting materials). But compound 12d unexpectedly gave dehydrofluorinated compound 13d as the major product under the reaction conditions according to 19 F NMR and 1 H NMR analysis of the reac-tion mixture and the crude product (Scheme 2). Unfortunately, all attempts to isolate the reactive compound 13d in a pure state failed. The deprotected fluorinated amino acids 14 could be quantitatively hydrolyzed in acidic conditions 29 to the corresponding acids 16 as hydrochloric salts. It was illustrated by the synthesis of Bn-protected amino acids 16a,b. Amino acids 11a,b were formed by catalytic hydrogenation of Bn-protected derivatives 16a,b at room temperature and 1 atm hydrogen pressure over Pd on carbon in MeOH-H 2 O media 30 as hydrochloric salts. These compounds were easily transformed into Boc- 
protected derivatives 18a,b 31 that are more convenient for utilizing as building blocks in parallel synthesis in comparison with Bn-protected derivatives. The orthogonal benzyl deprotection from the compound type 14 could be also accomplished by catalytic hydrogenation. 32 It was demonstrated by synthesis of the amino ester 15c. In the case of 4,4-difluoro--proline derivatives replacement of Bn protection group with TFA in substrate 19d changed the behavior of deoxofluorination. The standard SF 4 /HF protocol gave the desired difluoro derivative 20d in 71% preparative yield on 80 g scale of the used starting material. TFA deprotection by classical nucleophilic methodologies with such reagents as NH 2 NH 2 , NH 2 OH, or NaOMe is incompatible with enolizable ,-difluoroesters. Therefore, an alternative mild acidic deprotection method was applied. It was found that ethanolic solution of anhydrous HCl, generated by addition of acetyl chloride into EtOH, 33 selectively cleaved TFA amide, leaving the ester function intact. 34 In the case of compound 20d the method led to amino ester 15d in 90% yield as hydrochloride (Scheme 2).
A preparative solution for substrate 1j and its analogues was found. The ester group in these compounds could be exchanged to a nitrile. Deoxofluorination of keto nitriles 21a, 21j, and 21t proceeded smoothly in SF 4 /HF system according to protocol A1 at room temperature (Scheme 3). The desired ,-difluoronitriles 22a, 22j, and 22t were formed in moderate to good yields (46-78%) on 0.15-0. Finally, the reaction of deoxofluorination of -keto esters and -keto nitriles by SF 4 in anhydrous HF media was investigated. The scope and limitation of the reaction were determined. Substrates having steric hindrance at the keto group, bearing ArCH 2 O-, -NHTFA, and fragments capable of cationic-like rearrangements, are out of the scope of the procedure. The reaction was scaled up to 0.9 mol of starting material using 1200 mL Hastelloy autoclave. Work with such quantity of SF 4 required a special technique and equipment, which was also demonstrated. The promising build-ing blocks for medicinal chemistry, -difluorinated acids, were produced by hydrolysis of the appropriate esters on 100 g scale. Despite the serious difficulties of using toxic, hazardous SF 4 towards special lab space, equipment, personal protection, and staff skills, the elaborated methods are substantially more efficient in comparison with multistep sequences based on less hazardous fluorine sources. Moreover, the proposed protocol can be easily introduced into the production cycle at industrial facilities that use SF 4 A mixture of the ester 2 (1 equiv), formic acid (4 equiv), and 20% hydrochloric acid (3 equiv of HCl) was stirred at 100°C with 10 cm Vigreux column for 2 days. The reaction mixture was saturated with NaCl, and the product was extracted with dichloromethane (for the substance 2p, the precipitated product was filtered off and washed with cold water). The extracts were dried, evaporated, and distilled. The bp and yields of products 10 are given in Table 1 . A mixture of the ester 2 (1 equiv) and sodium hydroxide (1.5 equiv) in 50% aqueous ethanol (2 L per 1 mol) was boiled until the reaction was completed (from 1 night to 3 days). The reaction mixture was evaporated, acidified with hydrochloric acid, and the product was extracted with dichloromethane. The extracts were combined, dried, evaporated, and distilled. The bp and yields of products 10 are given in Table 1 .
Representative Examples 3,3-Difluorobutanoic Acid (10a)
Representative Examples 3,3-Difluoro-2,2-dimethylbutanoic Acid (10l)
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